The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma

The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma

Objective: To investigate the association between tumor PD-L1 expression and patient survival to determine whether PD-L1 represents an independent prognostic feature for patients with non-metastatic clear cell renal cell carcinoma (RCC).Patients and Methods: The tissue bank of the Fudan University S...

Full description

Bibliographic Details
Main Authors:	Wen-jun Xiao, Fu-jiang Xu, Xuan Zhang, Shu-xian Zhou, Hai-liang Zhang, Bo Dai, Yao Zhu, Guo-hai Shi, Yi-jun Shen, Yi-ping Zhu, Yuan-yuan Qu, Jian-yuan Zhao, Ding-wei Ye
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-11-01
Series:	Frontiers in Oncology
Subjects:	programmed death–ligand 1 renal cell carcinoma immunohistochemistry real-time polymerase chain reaction overall survival progression-free survival
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2019.00879/full

Similar Items

PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.
by: HongKai Wang, et al.
Published: (2017-01-01)

Intravesical Recurrence After Radical Nephroureterectomy of Upper Urinary Tract Urothelial Carcinoma: A Large Population-Based Investigation of Clinicopathologic Characteristics and Survival Outcomes
by: Jie Wu, et al.
Published: (2021-02-01)

Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer
by: Yi-Ping Zhu, et al.
Published: (2014-02-01)

Comparison of two adjuvant hormone therapy regimens in patients with high-risk localized prostate cancer after radical prostatectomy: primary results of study CU1005
by: Kun Chang, et al.
Published: (2016-01-01)

Primary tumor surgery improves survival in non-metastatic primary urethral carcinoma patients: a large population-based investigation
by: Jie Wu, et al.
Published: (2021-07-01)

Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy
by: Gui-Ming Zhang, et al.
Published: (2015-04-01)

Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer
by: Zheng Liu, et al.
Published: (2018-09-01)

Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a SEER analysis
by: Wen-Jun Xiao, et al.
Published: (2015-04-01)

Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy
by: Bo Zhao, et al.
Published: (2019-11-01)

The Role of Tumor Deposits in Predicting the Efficacy of Chemotherapy in Stage III Colon Cancer
by: Mingyu Shi, et al.
Published: (2020-10-01)

Yolk sac tumor in a patient with transverse testicular ectopia
by: Zhu Yi-Ping, et al.
Published: (2011-08-01)

Genitourinary small-cell carcinoma: 11-year treatment experience
by: Kun Chang, et al.
Published: (2014-10-01)

Promoter Methylation of DNA Repair Genes Predicts Disease-free Survival of Gastric Adenocarcinoma after Adjuvant Radiotherapy
by: Ning An, et al.
Published: (2020-09-01)

External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer
by: Yun-Jie Yang, et al.
Published: (2018-01-01)

Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis
by: Lijin Zhang, et al.
Published: (2019-07-01)

Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy
by: Hui Chang, et al.
Published: (2020-06-01)

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer
by: MierXiati Abudurexiti, et al.
Published: (2019-09-01)

Young-Onset Early Colorectal Cancer Had Similar Relative Survival to but Better Overall Survival Than Conventional Early Colorectal Cancer: A Large Population-Based Study
by: Jin-Nan Chen, et al.
Published: (2020-02-01)

Integrated Bioinformatics Analysis the Function of RNA Binding Proteins (RBPs) and Their Prognostic Value in Breast Cancer
by: Ke Wang, et al.
Published: (2019-03-01)

Stage‐dependent conditional survival and failure hazard of non‐metastatic nasopharyngeal carcinoma after intensity‐modulated radiation therapy: Clinical implications for treatment strategies and surveillance
by: Jingbo Wang, et al.
Published: (2021-06-01)

Effect of sidedness on survival among patients with early-stage colon cancer: a SEER-based propensity score matching analysis
by: Zhuang-Sheng Huang, et al.
Published: (2021-04-01)

Development of a prognostic scoring model for predicting the survival of elderly patients with hepatocellular carcinoma
by: Sizhe Wan, et al.
Published: (2020-02-01)

Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
by: Sumin Tang, et al.
Published: (2017-04-01)

Serum choline is associated with hepatocellular carcinoma survival: a prospective cohort study
by: Zhao-Yan Liu, et al.
Published: (2020-03-01)

Adjuvant Radiotherapy After Minimally Invasive Surgery in Patients With Stage IA1-IIA1 Cervical Cancer
by: Yi-xiu Gan, et al.
Published: (2021-07-01)

The impact of Pegylated liposomal doxorubicin in recurrent ovarian cancer: an updated meta-analysis of randomized clinical trials
by: Xin-Ru Li, et al.
Published: (2021-03-01)

Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
by: Run-Cong Nie, et al.
Published: (2020-05-01)

Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer
by: Jin-Ye Fu, et al.
Published: (2021-06-01)

Evaluation of Eight Different Clinical Staging Systems Associated with Overall Survival of Chinese Patients with Hepatocellular Carcinoma
by: Jian-Jun Zhao, et al.
Published: (2015-01-01)

Association Between Circulating Lymphocyte Populations and Outcome After Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma
by: Yuan Zhuang, et al.
Published: (2019-09-01)

Analysis on Lung Cancer Survival from 2001 to 2007 in Qidong, China
by: Jian ZHU, et al.
Published: (2011-01-01)

Combination of body mass index and albumin predicts the survival in metastatic castration‐resistant prostate cancer patients treated with abiraterone: A post hoc analysis of two randomized trials
by: Jian Pan, et al.
Published: (2021-10-01)

Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma
by: Wen-Hao Xu, et al.
Published: (2019-11-01)

Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women
by: Jinsong Su, et al.
Published: (2019-01-01)

Perioperative risk factors for survival outcomes in elective colorectal cancer surgery: a retrospective cohort study
by: Xing-Xing Liu, et al.
Published: (2021-04-01)

Impact of postoperative complications on long-term outcomes of patients following surgery for gastric cancer: A systematic review and meta-analysis of 64 follow-up studies
by: Jian Li, et al.
Published: (2020-07-01)

Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma
by: Yuan‐Deng Luo, et al.
Published: (2020-06-01)

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis
by: Dechuang Jiao, et al.
Published: (2021-02-01)

Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients
by: Meng Sun, et al.
Published: (2020-09-01)

Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study
by: Jin-Li Wei, et al.
Published: (2018-12-01)